These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10936301)

  • 21. Primary nonfunction is a major barrier to cardiac xenograft but not allograft mouse-ear cardiac transplants.
    Thomas FT; Araneda D
    Transplant Proc; 1992 Apr; 24(2):503-4. PubMed ID: 1566405
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of accommodation prevents hyperacute rejection.
    Vriens PW; Bouwman E; Scheringa M
    Transplant Proc; 1997; 29(1-2):597-8. PubMed ID: 9123147
    [No Abstract]   [Full Text] [Related]  

  • 23. Brequinar sodium and liver hemoperfusion in xenotransplantation.
    Chastanet S; Cursio R; Gugenheim J; Baldini E; Chevallier A; Damais A; Charpentier B; Mouiel J
    Transplant Proc; 1998 Aug; 30(5):2244-5. PubMed ID: 9723457
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of various routes of donor-specific antigen administration on graft survival in a model of discordant heart xenotransplantation.
    Akpinar E; Arikan U; Bilgin N
    Transplant Proc; 1998 May; 30(3):809-11. PubMed ID: 9595108
    [No Abstract]   [Full Text] [Related]  

  • 25. New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders.
    Jagroop IA; Mikhailidis DP
    Curr Drug Targets; 2001 Mar; 2(1):107-8. PubMed ID: 11465536
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged survival of guinea-pig-to-rat heart xenografts following complement depletion and B-cell-directed immunosuppression by malononitrilamide.
    Meyer zu Vilsendorf A; Nagel E; Link C; Jörns A; Köhl J
    Transplant Proc; 2000 Aug; 32(5):864-5. PubMed ID: 10936248
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolongation of graft survival in the concordant hamster-to-rat cardiac model.
    Brouard S; Blancho G; Moreau A; Heslan JM; Cuturi MC; Soulillou JP
    Transplant Proc; 1998 Aug; 30(5):2486-7. PubMed ID: 9723549
    [No Abstract]   [Full Text] [Related]  

  • 28. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo 31P MRS evaluation of the rejection process and differences in anesthetic procedures in a concordant xenotransplantation: mouse heart to rat modell.
    Lukes D; Madhou B; Arvidsson N; Gustavsson M; Mjörnstedt L; Soussi B; Olausson M
    Transplant Proc; 1997 Nov; 29(7):3159-60. PubMed ID: 9365708
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of cholera toxin in xenograft survival.
    Sakakibara N; Tsuru S; Shinomiya N; Click RE; Hirata K; Jamieson SW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):423-4. PubMed ID: 8438363
    [No Abstract]   [Full Text] [Related]  

  • 31. Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model.
    Flores HC; Leventhal JR; Gruber SA; Figueroa J; Platt JL; Manivel C; Bach FH; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):714. PubMed ID: 1566495
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of xenograft rejection on future grafting.
    Gannedahl G; Tufveson G
    Transplant Proc; 1992 Feb; 24(1):276-8. PubMed ID: 1539281
    [No Abstract]   [Full Text] [Related]  

  • 33. Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1.
    Xia W; Fearon DT; Moore FD; Schoen FJ; Ortiz F; Kirkman RL
    Transplant Proc; 1992 Apr; 24(2):479-80. PubMed ID: 1566395
    [No Abstract]   [Full Text] [Related]  

  • 34. Three-month survival of HDAFF transgenic pig hearts transplanted into primates.
    Bhatti FN; Schmoeckel M; Zaidi A; Cozzi E; Chavez G; Goddard M; Dunning JJ; Wallwork J; White DJ
    Transplant Proc; 1999; 31(1-2):958. PubMed ID: 10083425
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term survival of hamster hearts in presensitized rats.
    Wang N; Lee JM; Soares MP; Csizmadia E; Robson SC; Smith N; Bach FH; Lin Y
    Transplant Proc; 2001; 33(1-2):747-8. PubMed ID: 11267051
    [No Abstract]   [Full Text] [Related]  

  • 36. Persistence of tumor necrosis factor production in long-surviving concordant cardiac xenografts.
    Peterson SM; Noble BK; Gorfien J; Hoover EL; Bergsland J
    Transplant Proc; 1994 Jun; 26(3):1342-3. PubMed ID: 8029933
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolongation of cardiac xenograft survival by pre- and posttransplant splenectomy is associated with a decrease in anti-donor antibody titers.
    Quarantillo P; Araneda D; Thomas F; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):387-8. PubMed ID: 8438347
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporine induces long-term xenograft survival in the mouse-to-C6-deficient rat heart transplantation model.
    Wu GS; Korsgren O; Tibell A
    Transplant Proc; 2000 Aug; 32(5):1015. PubMed ID: 10936325
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
    Zhang Z; Zhong R; Jiang J; Wang J; Garcia B; Le Feuvre C; White M; Stiller C; Lazarovits A
    Transplant Proc; 1997; 29(1-2):1253. PubMed ID: 9123294
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between graft mass and graft survival time in a discordant cardiac xenotransplantation model: a preliminary report.
    Akpinar E; Arikan U; Bilgin N
    Transplant Proc; 1998 May; 30(3):812-3. PubMed ID: 9595109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.